• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies. Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland
In an effort to raise awareness for alternatives to animal models, BioVox is helping to promote an Organ-on-Chip initiative by Dutch startup Bi/ond. The initiative aims to increase awareness and adoption of Organ-on-Chip technology, to improve in vitro research models and reduce animal testing.
We recently sat down with Sjaak Vink, the visionary entrepreneur behind TheSocialMedwork. This enterprise gives patients all over the world access to medication that has not yet been approved in their home countries. We spoke with Vink about his personal motivations for founding TheSocialMedwork and his dream for universal basic healthcare.
PRESS RELEASE Amsterdam/Beerse, November 25, 2019 – Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further develop and ultimately commercialize food supplements based on specific microbiota for the purpose of early intervention and nutritional management of diabetes and certain liver disorders.
  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies. Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland
In an effort to raise awareness for alternatives to animal models, BioVox is helping to promote an Organ-on-Chip initiative by Dutch startup Bi/ond. The initiative aims to increase awareness and adoption of Organ-on-Chip technology, to improve in vitro research models and reduce animal testing.
We recently sat down with Sjaak Vink, the visionary entrepreneur behind TheSocialMedwork. This enterprise gives patients all over the world access to medication that has not yet been approved in their home countries. We spoke with Vink about his personal motivations for founding TheSocialMedwork and his dream for universal basic healthcare.
PRESS RELEASE Amsterdam/Beerse, November 25, 2019 – Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further develop and ultimately commercialize food supplements based on specific microbiota for the purpose of early intervention and nutritional management of diabetes and certain liver disorders.